TRIP13 and lung carcinoma: To verify the impact of TRIP13 on lung cancer, A549 cells were infected with a TRIP13 overexpression lentiviral, and the cell proliferation was evaluated via CCK8 assay, the results indicated that TRIP13 was overexpressed successfully (Fig. 11A), and cell proliferation was significantly facilitated compared with the control (Fig. 11B).